We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Tilray Brands (TLRY) Q1 Loss Wider, Revenues Increase Y/Y
Read MoreHide Full Article
Tilray Brands, Inc. (TLRY - Free Report) reported wider-than-expected loss in first-quarter fiscal 2024, while the top line beat the Zacks Consensus Estimate.
Over the past three months, shares of this current Zacks Rank #3 (Hold) player have increased 41.3% against the industry’s 17.1% drop.
Q1 Highlights
Tilray Brands posted quarterly loss of 10 cents a share, wider than the Zacks Consensus Estimate of a loss of 5 cents per share. However, the company reported a loss of 13 cents per share in the prior-year period.
Total revenues jumped 15% year over year to $177 million and came above the consensus estimate of $175 million. Cannabis net revenues climbed 20% to $70 million, while net cannabis revenues were $71 million in the quarter, up 22% on a constant-currency basis. Beverage alcohol net revenues jumped 17% to $24 million. Distribution net revenues rose 14% to $69 million, while on a constant-currency basis, distribution revenues came in at $67 million, up 11% from the prior- year quarter.
Tilray Brands, Inc. Price, Consensus and EPS Surprise
Adjusted gross profit was $49 million in the quarter, while the adjusted gross margin contracted 400 basis points from the prior-year quarter to 28%.
Adjusted EBITDA came in at $11.4 million, down from $13.5 million in the prior-year quarter, mainly owing to the prior-year HEXO advisory fee revenues.
The company achieved $17.1 million in annualized run-rate savings, which are related to the $27 million synergy plan in connection with the HEXO acquisition. It is on track to achieve its integration plan goals and is confident that HEXO will be a successful acquisition. It has accomplished $6.8 million in annualized run-rate savings related to the $8 million cost reduction plan in Europe.
Other Financial Aspects
Tilray Brands ended the reported quarter with cash and cash equivalents of $177.5 million, net accounts receivable of $82.1 million and stockholders’ equity of $3,379.4 million, excluding non-controlling interest of $22.2 million.
Outlook
For the fiscal year ending May 31, 2024, management reiterated adjusted EBITDA of $68-$78 million, indicating growth of 11-27% versus fiscal 2023.
Additionally, the company anticipates generating positive adjusted free cash flow.
The Zacks Consensus Estimate for Inter Parfums’ current financial-year sales indicates 19.7% growth from the year-ago reported figure. IPAR has a trailing four-quarter earnings surprise of 45.9% on average.
Helen of Troy (HELE - Free Report) , a provider of several consumer products, currently has a Zacks Rank #2 (Buy). HELE’s expected earnings per share growth rate for three to five years is 8%.
The Zacks Consensus Estimate for Helen of Troy’s current fiscal-year sales suggests a decline of 2.9% from the year-ago reported numbers. HELE has a trailing four-quarter earnings surprise of 8.1%, on average.
Ingredion Inc. (INGR - Free Report) , a producer and distributor of sweeteners, nutrition ingredients and biomaterial solutions, currently carries a Zacks Rank of 2.
The Zacks Consensus Estimate for INGR’s current financial-year earnings per share is expected to rise 23.9% from the corresponding year-ago reported figure.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Tilray Brands (TLRY) Q1 Loss Wider, Revenues Increase Y/Y
Tilray Brands, Inc. (TLRY - Free Report) reported wider-than-expected loss in first-quarter fiscal 2024, while the top line beat the Zacks Consensus Estimate.
Over the past three months, shares of this current Zacks Rank #3 (Hold) player have increased 41.3% against the industry’s 17.1% drop.
Q1 Highlights
Tilray Brands posted quarterly loss of 10 cents a share, wider than the Zacks Consensus Estimate of a loss of 5 cents per share. However, the company reported a loss of 13 cents per share in the prior-year period.
Total revenues jumped 15% year over year to $177 million and came above the consensus estimate of $175 million. Cannabis net revenues climbed 20% to $70 million, while net cannabis revenues were $71 million in the quarter, up 22% on a constant-currency basis. Beverage alcohol net revenues jumped 17% to $24 million. Distribution net revenues rose 14% to $69 million, while on a constant-currency basis, distribution revenues came in at $67 million, up 11% from the prior- year quarter.
Tilray Brands, Inc. Price, Consensus and EPS Surprise
Tilray Brands, Inc. price-consensus-eps-surprise-chart | Tilray Brands, Inc. Quote
Adjusted gross profit was $49 million in the quarter, while the adjusted gross margin contracted 400 basis points from the prior-year quarter to 28%.
Adjusted EBITDA came in at $11.4 million, down from $13.5 million in the prior-year quarter, mainly owing to the prior-year HEXO advisory fee revenues.
The company achieved $17.1 million in annualized run-rate savings, which are related to the $27 million synergy plan in connection with the HEXO acquisition. It is on track to achieve its integration plan goals and is confident that HEXO will be a successful acquisition. It has accomplished $6.8 million in annualized run-rate savings related to the $8 million cost reduction plan in Europe.
Other Financial Aspects
Tilray Brands ended the reported quarter with cash and cash equivalents of $177.5 million, net accounts receivable of $82.1 million and stockholders’ equity of $3,379.4 million, excluding non-controlling interest of $22.2 million.
Outlook
For the fiscal year ending May 31, 2024, management reiterated adjusted EBITDA of $68-$78 million, indicating growth of 11-27% versus fiscal 2023.
Additionally, the company anticipates generating positive adjusted free cash flow.
Some Solid Staple Bets
Inter Parfums (IPAR - Free Report) , which manufactures, markets and distributes a range of fragrances and fragrance-related products, currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Inter Parfums’ current financial-year sales indicates 19.7% growth from the year-ago reported figure. IPAR has a trailing four-quarter earnings surprise of 45.9% on average.
Helen of Troy (HELE - Free Report) , a provider of several consumer products, currently has a Zacks Rank #2 (Buy). HELE’s expected earnings per share growth rate for three to five years is 8%.
The Zacks Consensus Estimate for Helen of Troy’s current fiscal-year sales suggests a decline of 2.9% from the year-ago reported numbers. HELE has a trailing four-quarter earnings surprise of 8.1%, on average.
Ingredion Inc. (INGR - Free Report) , a producer and distributor of sweeteners, nutrition ingredients and biomaterial solutions, currently carries a Zacks Rank of 2.
The Zacks Consensus Estimate for INGR’s current financial-year earnings per share is expected to rise 23.9% from the corresponding year-ago reported figure.